newsfilter
← Latest News
GlobeNewswire·

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K

SAN DIEGO, CA, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB:SIGY) ("Sigyn Therapeutics" or the "Company"), a development-stage company that creates blood purification